Select Medical Holdings Corporation (NYSE:SEM) Q1 2024 Earnings Conference Call May 3, 2024 9:00 AM ET Company Participants Robert Ortenzio - Chief Executive Chairman and Co-Founder Martin Jackson - Senior EVP, Strategic Finance & Operations Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendrix - RBC Capital Markets A.J. Rice - UBS Bill Sutherland - The Benchmark Company Operator Good morning and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Ca ...

Exhibit 99.1 FOR IMMEDIATE RELEASE 4714 Gettysburg Road Mechanicsburg, PA 17055 NYSE Symbol: SEM Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2024 and Cash Dividend MECHANICSBURG, PENNSYLVANIA — May 2, 2024 — Select Medical Holdings Corporation (“Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) today announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend. For the first quarter ended March 31, 2024, revenue increas ...

收入情况 - 公司总收入为17.89亿美元，同比增长7.4%[41] - 重症康复医院板块收入为6.56亿美元，同比增长10.4%[42] - 康复医院板块收入为2.66亿美元，同比增长14.8%[45] - 门诊康复板块收入为3.03亿美元，同比增长2.5%[45] - Concentra板块收入为4.68亿美元，同比增长2.5%[45] - 公司收入同比增长7.4%，达到17.89亿美元[62] - 关键业务分部收入表现良好: - 重症监护医院收入增长10.4%[63] - 康复医院收入增长14.8%[64] - 门诊康复收入增长2.5%[64] - Concentra收入增长2.5%[64] 利润情况 - 公司调整后息税折旧摊销前利润(Adjusted EBITDA)为2.62亿美元，同比增长22.4%[44] - 公司净利润为1.17亿美元,同比增长37.4%[45] - 整体利润率提升，调整后EBITDA同比增长22.4%，达到2.62亿美元[62] - 重症监护医院调整后EBITDA率提升至17.7%[62] - 康复医院调整后EBITDA率提升至23.1%[62] - 门诊康复调整后EBITDA率下降至8.2%[62] - Concentra调整后EBITDA率维持在20.6%[62] - 关键疾病康复医院分部的调整后EBITDA增加51.0%至1.159亿美元，调整后EBITDA利润率从12.9%上升至17.7%[66] - 康复医院分部的调整后EBITDA增加30.0%至6,140万美元，调整后EBITDA利润率从20.4%上升至23.1%[66] 现金流和资本支出 - 受Change Healthcare网络安全事件影响,公司营运现金流有所下降,但整体财务状况仍保持良好[43] - 公司三个月内的营运现金流为-6,668.9万美元，较上年同期的5,144万美元下降，主要由于应收账款增加所致[67] - 公司三个月内的资本开支为5,765.7万美元，主要用于购置物业、设备和其他资产[67] - 公司三个月内通过借款活动获得1.329亿美元现金流入，主要来自于在循环信贷额度下的借款[67] - 公司在2024年3月31日的可用循环信贷额度为2.024亿美元[69] 股利和财务状况 - 公司董事会宣布派发每股0.125美元的现金股利[70] - 公司面临劳动力成本上升和供应商价格上涨的通胀压力[70] - 公司于2024年3月31日有20.13亿美元的定期贷款和5.1亿美元的循环贷款[72] - 公司已经采取利率上限协议,限制2000万美元定期贷款的利率不超过1%,协议有效期至2024年9月30日[72] - 2024年3月31日,公司13.4百万美元的定期贷款利率为浮动利率,其余部分将在2024年9月30日利率上限协议到期后转为浮动利率[73] - 每增加0.25%的市场利率,将使公司浮动利率债务的年利息费用增加380万美元[73] 监管政策变化 - 2023年5月11日公共卫生紧急状态结束后,长期护理医院(LTCH)不再豁免Medicare法定要求,需要重新满足平均住院时间大于25天的条件[46] - 2023财年LTCH标准联邦费率为46,433美元,较2022财年的44,714美元上涨4.1%[48] - 2024财年LTCH标准联邦费率为48,117美元,较2023财年的46,433美元上涨3.5%[49] - 2025财年LTCH标准联邦费率拟定为49,263美元,较2024财年的48,117美元上涨3.2%[49] - 2023财年IRF标准支付转换因子为17,878美元,较2022财年的17,240美元上涨4.2%[50] - 2024财年IRF标准支付转换因子为18,541美元,较2023财年的17,878美元上涨3.6%[51] - 2025财年IRF标准支付转换因子拟定为18,872美元,较2024财年的18,541美元上涨3.2%[52] - 2024年Medicare门诊康复诊所服务支付将下降约3%[53] - 2024年3月9日通过的《2024年综合拨款法案》将减轻Medicare医生支付降幅,从3.37%降至1.69%[53] 业务发展计划 - 公司计划在2024财年内完成Concentra业务的分拆上市[42][43] 运营数据 - 公司三个月内的就诊人次为3,155,655人次，较上年同期的3,217,945人次有所下降[65] - 运营费用占收入比例从上年同期的87.7%下降至86.3%，主要归因于关键疾病康复医院和康复医院分部收入增加[65]

Select Medical Holdings Corporation (NYSE:SEM) Q4 2023 Earnings Conference Call February 23, 2024 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman & Co-Founder Martin Jackson - EVP & CFO Conference Call Participants Justin Bowers - Deutsche Bank Kevin Fischbeck - Bank of America Ben Hendrix - RBC Capital Markets Bill Sutherland - The Benchmark Company A.J. Rice - UBS Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Ca ...

Exhibit 99.1 FOR IMMEDIATE RELEASE 4714 Gettysburg Road Mechanicsburg, PA 17055 NYSE Symbol: SEM Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2023 and Cash Dividend MECHANICSBURG, PENNSYLVANIA — February 22, 2024 — Select Medical Holdings Corporation (“Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) today announced results for its fourth quarter and year ended December 31, 2023 and the declaration of a cash dividend. For the fourth quarter ended ...

Use these links to rapidly review the document TABLE OF CONTENTS INDEX TO FINANCIAL STATEMENTS Table of Contents 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbers: 001-34465 SELECT MEDICAL HOLDINGS C ...

Select Medical Holdings Corporation (NYSE:SEM) Q3 2023 Earnings Conference Call November 3, 2023 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman & Co-Founder Martin Jackson - EVP & CFO Conference Call Participants Justin Bowers - Deutsche Bank Michael Murray - RBC Capital Markets William Sutherland - The Benchmark Company Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the Third Quarter 2023 Results ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbers: 001-34465 SELECT MEDICAL HOLDINGS CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 20-1764048 (Stat ...

Select Medical Holdings Corporation (NYSE:SEM) Q2 2023 Earnings Conference Call August 4, 2023 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman & Co-Founder Martin Jackson - EVP & CFO Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendrix - RBC Capital Markets Kevin Fischbeck - Bank of America Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the Second Quarter 2023 Results and the busin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbers: 001-34465 SELECT MEDICAL HOLDINGS CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 20-1764048 (State or ...